Have You experienced a side effect?
and Vote

Yes, Severe
Yes, Moderate
Yes, Minor
No
Discuss Results
1.5 million people annually are harmed from drug errors. Side Effects Reported Today:

Don't Risk Your Health!
Ask a Health Expert Now


OCULAR HYPERTENSION side effect

What is OCULAR HYPERTENSION ?
Help Community - Describe Your Side Effect   Search FDA Side Effects   Ask Health Expert   OCULAR HYPERTENSION and Recently Reported Side Effects   OCULAR HYPERTENSION and 15 most Active Side Effect polls   OCULAR HYPERTENSION and featured health surveys   Substances toxic to Health   Recent Hospital reviews   Comments about Side Effects   Hospital Quality reviews   Homecare Quality reviews
Health Expert

A Health Expert wants to answer your question.

Please provide details below.



Drugs associated with OCULAR HYPERTENSION

BYETTA  CHAMPIX  COMBIVENT  CYMBALTA  LUCENTIS  LYRICA  OMNIC  OPTRUMA  RANIBIZUMAB  RHINOCORT  TIMOPTIC  TRILEPTAL  VIRAFERONPEG  


Byetta Side Effects Report #5442163-5
Consumer or non-health professional from UNITED STATES reported BYETTA problem on May 27, 2007. Female patient, 79 years of age, weighting 239.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: ocular hypertension, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE PEN, AVANDIA, HUMALOG. Patient recovered.

Byetta Side Effects Report #5442163-5
BYETTA problem was reported by a Consumer or non-health professional from UNITED STATES on May 27, 2007. Female patient, 79 years of age, weighting 239.9 lb, was diagnosed with insulin-requiring type ii diabetes mellitus and was treated with BYETTA. After drug was administered, patient experienced the following problems/side effects: ocular hypertension, weight decreased, . BYETTA dosage: unknown. During the same period patient was treated with EXENATIDE PEN, AVANDIA, HUMALOG. Patient recovered.

Cymbalta Side Effects Report #5788030-9
Physician from FRANCE reported CYMBALTA problem on June 13, 2008. Male patient, 42 years of age, was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: ocular hypertension, . CYMBALTA dosage: 60 MG, DAILY (1/D). Patient recovered.

Lucentis Side Effects Report #5753677-2
LUCENTIS problem was reported by a Consumer or non-health professional from UNITED STATES on May 22, 2008. Female patient, 72 years of age, was treated with LUCENTIS. After drug was administered, patient experienced the following problems/side effects: ocular hypertension, . LUCENTIS dosage: unknown. During the same period patient was treated with BEVACIZUMAB. Patient recovered.


Rhinocort Side Effects Report #5709290-6
Physician from FRANCE reported RHINOCORT problem on Apr 09, 2008. Male patient, 61 years of age, was diagnosed with nasal polyps, hypertension and was treated with RHINOCORT. After drug was administered, patient experienced the following problems/side effects: ocular hypertension, . RHINOCORT dosage: unknown. During the same period patient was treated with TARKA LP. Patient recovered.

Trileptal Side Effects Report #5267001-5
TRILEPTAL problem was reported by a Physician from FRANCE on Mar 05, 2007. Female patient, 50 years of age, was diagnosed with bipolar disorder and was treated with TRILEPTAL. After drug was administered, patient experienced the following problems/side effects: ocular hypertension, . TRILEPTAL dosage: unknown. Patient recovered.

Viraferonpeg Side Effects Report #5493119-8
Physician from FRANCE reported VIRAFERONPEG problem on Oct 15, 2007. Male patient, 70 years of age, weighting 154.3 lb, was diagnosed with hepatitis c and was treated with VIRAFERONPEG. After drug was administered, patient experienced the following problems/side effects: iridocyclitis, ocular hypertension, . VIRAFERONPEG dosage: unknown. During the same period patient was treated with REBETOL, EPREX. Patient recovered.

Lyrica Side Effects Report #5406563-1
LYRICA problem was reported by a Pharmacist from FRANCE on July 30, 2007. Female patient, weighting 103.6 lb, was diagnosed with facial palsy, insomnia, migraine, anxiety and was treated with LYRICA. After drug was administered, patient experienced the following problems/side effects: glaucoma, ocular hypertension, . LYRICA dosage: unknown. During the same period patient was treated with KARDEGIC, CALCIUM W, POVIDONE, ZOPICLONE, PROTHIADEN, NARAMIG, BROMAZEPAM. Patient recovered.

Viraferonpeg Side Effects Report #5415317-1
Physician from FRANCE reported VIRAFERONPEG problem on Aug 02, 2007. Male patient, 70 years of age, weighting 154.3 lb, was diagnosed with hepatitis c and was treated with VIRAFERONPEG. After drug was administered, patient experienced the following problems/side effects: iridocyclitis, ocular hypertension, . VIRAFERONPEG dosage: unknown. During the same period patient was treated with REBETOL, EPREX. Patient recovered.


Omnic Side Effects Report #5777739-9
OMNIC OCAS ORODISPERSABLE problem was reported by a Physician from SPAIN on June 02, 2008. Male patient, 57 years of age, was diagnosed with benign prostatic hyperplasia and was treated with OMNIC OCAS ORODISPERSABLE. After drug was administered, patient experienced the following problems/side effects: ocular hyperaemia, ocular hypertension, vision blurred, . OMNIC OCAS ORODISPERSABLE dosage: unknown. Patient recovered.

Optruma Side Effects Report #5779420-9
Consumer or non-health professional from FRANCE reported OPTRUMA problem on June 06, 2008. Female patient, 60 years of age, was treated with OPTRUMA. After drug was administered, patient experienced the following problems/side effects: breast enlargement, ocular hypertension, visual acuity reduced, . OPTRUMA dosage: unknown. Patient recovered.

Combivent Side Effects Report #5701185-7
COMBIVENT problem was reported by a Physician from on Mar 31, 2008. Female patient, 59 years of age, was diagnosed with bronchitis and was treated with COMBIVENT. After drug was administered, patient experienced the following problems/side effects: eye irritation, ocular hypertension, skin exfoliation, visual acuity reduced, . COMBIVENT dosage: 500MCG IPRATROPIUMBROMID/ 2,5MG SALBUTAMOL. During the same period patient was treated with LYSOMUCIL. Patient recovered.

Cymbalta Side Effects Report #5330214-8
Physician from BRAZIL reported CYMBALTA problem on May 08, 2007. Male patient was diagnosed with depression and was treated with CYMBALTA. After drug was administered, patient experienced the following problems/side effects: angle closure glaucoma, ocular hypertension, . CYMBALTA dosage: 120 MG, DAILY (1/D). During the same period patient was treated with BUPROPION HYDROCHLORIDE. Patient recovered.

Champix Side Effects Report #5330498-6
CHAMPIX problem was reported by a Consumer or non-health professional from PORTUGAL on May 09, 2007. Male patient, 42 years of age, was diagnosed with ex-smoker and was treated with CHAMPIX. After drug was administered, patient experienced the following problems/side effects: eye pain, ocular hypertension, . CHAMPIX dosage: unknown. Patient recovered.


Timoptic Side Effects Report #5267240-3
Consumer or non-health professional from UNITED STATES reported TIMOPTIC problem on Feb 27, 2007. Female patient was treated with TIMOPTIC. After drug was administered, patient experienced the following problems/side effects: amnesia, ocular hypertension, senile dementia, . TIMOPTIC dosage: unknown. During the same period patient was treated with ALPHAGAN. Patient recovered.

Ranibizumab Side Effects Report #5520193-2
RANIBIZUMAB problem was reported by a Consumer or non-health professional from SWITZERLAND on Nov 02, 2007. Female patient, weighting 110.2 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal oedema, eye pain, ocular hypertension, overdose, visual acuity reduced, . RANIBIZUMAB dosage: unknown. During the same period patient was treated with LISINOPRIL, GASTER, SENNOSIDE, HALCION, MEVALOTIN, DEPAS, APROMAL, COFFEINE. Patient recovered.

Ranibizumab Side Effects Report #5468846-9
Consumer or non-health professional from SWITZERLAND reported RANIBIZUMAB problem on Sept 12, 2007. Female patient, weighting 110.2 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal oedema, eye pain, ocular hypertension, overdose, visual acuity reduced, . RANIBIZUMAB dosage: unknown. During the same period patient was treated with LISINOPRIL, FAMOTIDINE, SENNOSIDE, HALCION, PRAVASTATIN, DEPAS, APROMAL, COFFEINE. Patient recovered.

Ranibizumab Side Effects Report #5410232-1
RANIBIZUMAB problem was reported by a Consumer or non-health professional from SWITZERLAND on Aug 03, 2007. Male patient, weighting 141.1 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: intraocular pressure increased, ocular hypertension, overdose, visual acuity reduced, visual disturbance, . RANIBIZUMAB dosage: 0.05 ML, 1/MONTH. Patient recovered.

Ranibizumab Side Effects Report #5386770-7
Consumer or non-health professional from SWITZERLAND reported RANIBIZUMAB problem on July 02, 2007. Female patient, weighting 110.2 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal oedema, eye pain, ocular hypertension, overdose, visual acuity reduced, . RANIBIZUMAB dosage: unknown. During the same period patient was treated with LISINOPRIL, GASTER, SENNOSIDE, HALCION, PRAVASTATIN, DEPAS, APROMAL, COFFEINE. Patient recovered.


Ranibizumab Side Effects Report #5395254-1
RANIBIZUMAB problem was reported by a Consumer or non-health professional from SWITZERLAND on July 13, 2007. Female patient, weighting 110.2 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal oedema, eye pain, ocular hypertension, overdose, visual acuity reduced, . RANIBIZUMAB dosage: unknown. During the same period patient was treated with LISINOPRIL, FAMOTIDINE, SENNOSIDE, HALCION, PRAVASTATIN, DEPAS, APROMAL, COFFEINE. Patient recovered.

Ranibizumab Side Effects Report #5386770-7
Consumer or non-health professional from SWITZERLAND reported RANIBIZUMAB problem on July 02, 2007. Female patient, weighting 110.2 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal oedema, eye pain, ocular hypertension, overdose, visual acuity reduced, . RANIBIZUMAB dosage: unknown. During the same period patient was treated with LISINOPRIL, GASTER, SENNOSIDE, HALCION, PRAVASTATIN, DEPAS, APROMAL, COFFEINE. Patient recovered.

Ranibizumab Side Effects Report #5395254-1
RANIBIZUMAB problem was reported by a Consumer or non-health professional from SWITZERLAND on July 13, 2007. Female patient, weighting 110.2 lb, was treated with RANIBIZUMAB. After drug was administered, patient experienced the following problems/side effects: corneal oedema, eye pain, ocular hypertension, overdose, visual acuity reduced, . RANIBIZUMAB dosage: unknown. During the same period patient was treated with LISINOPRIL, FAMOTIDINE, SENNOSIDE, HALCION, PRAVASTATIN, DEPAS, APROMAL, COFFEINE. Patient recovered.

PatientsVille.com does not provide medical advice, diagnosis or treatment. The information contained on PatientsVille.com site has not been scientifically or otherwise verified as to a cause and effect relationship and cannot be used to estimate the incidence of adverse drug reactions or for establishing or changing of patient treatments.


Thank you for visiting Patientsville.com. We hope you found our information about OCULAR HYPERTENSION side effects helpful. The material on this site is for informational purposes only, and is not a substitute for medical advice, diagnosis or treatment provided by a qualified health care provider. Thank you for visiting Patientsville.net. Hope you enjoyed finding information on medications and found answers to Your Questions about OCULAR HYPERTENSION